References
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;1:3021–3104.
- Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9:307–309.
- Manios ED, Koroboki EA, Tsivgoulis GK, et al. Factors influencing white-coat effect. Am J Hypertens. 2008;21:153–158.
- Grassi G, Turri C, Vailati S, et al. Muscle and skin sympathetic nerve traffic during the “white-coat” effect. Circulation. 1999;100:222–225.
- Jhalani J, Goyal T, Clemow L, et al. Anxiety and outcome expectations predict the white-coat effect. Blood Press Monit. 2005;10:317–319.
- Schutte AE, Huisman HW, van Rooyen JM, et al. Validation of the Finometer device for measurement of blood pressure in black women. J Hum Hypertens. 2004;18:79–84.
- Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al. Unattended blood pressure measurements in the systolic blood pressure intervention trial. Hypertension. 2016;67:808–812.
- Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–2198.
- Huang Y, Huang W, Mai W, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677–688.
- Franklin SS, Thijs L, Hansen TW, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564–571.
- Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127–e248.
- Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045–1050.
- Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;356:i4098
- Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;13:895–905.
- Roest AM, Martens E, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;29:38–46.
- Portegies ML, Bos MJ, Koudstaal PJ, et al. Anxiety and the risk of stroke: the Rotterdam study. Stroke. 2016;47:1120–1123.